Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report

被引:129
作者
Akbani, Rehan [1 ]
Becker, Karl-Friedrich [2 ]
Carragher, Neil [3 ]
Goldstein, Ted [4 ]
de Koning, Leanne [5 ]
Korf, Ulrike [6 ]
Liotta, Lance [7 ]
Mills, Gordon B. [1 ]
Nishizuka, Satoshi S. [8 ]
Pawlak, Michael [10 ]
Petricoin, Emanuel F. [7 ]
Pollard, Harvey B. [9 ]
Serrels, Bryan [3 ]
Zhu, Jingchun
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Tech Univ Munich, D-80290 Munich, Germany
[3] Univ Edinburgh, MRC Inst Genet & Mol Med, Edinburgh Canc Res UK Ctr, Edinburgh, Midlothian, Scotland
[4] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA
[5] Inst Curie, Paris, France
[6] German Canc Res Ctr, Heidelberg, Germany
[7] George Mason Univ, Fairfax, VA 22030 USA
[8] Iwate Med Univ, Morioka, Iwate 020, Japan
[9] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[10] Nat & Med Sci Inst, Reutlingen, Germany
关键词
PARAFFIN-EMBEDDED TISSUES; HUMAN BREAST-CANCER; PATHWAY-ACTIVATION; CELL-LINES; MICROARRAY ANALYSIS; PROTEOMIC ANALYSIS; MEMBRANE-PROTEINS; SYSTEMS-ANALYSIS; DRUG DISCOVERY; BIOMARKER;
D O I
10.1074/mcp.O113.034918
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Reverse phase protein array (RPPA) technology introduced a miniaturized "antigen-down" or "dot-blot" immunoassay suitable for quantifying the relative, semi-quantitative or quantitative (if a well-accepted reference standard exists) abundance of total protein levels and post-translational modifications across a variety of biological samples including cultured cells, tissues, and body fluids. The recent evolution of RPPA combined with more sophisticated sample handling, optical detection, quality control, and better quality affinity reagents provides exquisite sensitivity and high sample throughput at a reasonable cost per sample. This facilitates large-scale multiplex analysis of multiple post-translational markers across samples from in vitro, preclinical, or clinical samples. The technical power of RPPA is stimulating the application and widespread adoption of RPPA methods within academic, clinical, and industrial research laboratories. Advances in RPPA technology now offer scientists the opportunity to quantify protein analytes with high precision, sensitivity, throughput, and robustness. As a result, adopters of RPPA technology have recognized critical success factors for useful and maximum exploitation of RPPA technologies, including the following: preservation and optimization of pre-analytical sample quality, application of validated high-affinity and specific antibody (or other protein affinity) detection reagents, dedicated informatics solutions to ensure accurate and robust quantification of protein analytes, and quality-assured procedures and data analysis workflows compatible with application within regulated clinical environments. In 2011, 2012, and 2013, the first three Global RPPA workshops were held in the United States, Europe, and Japan, respectively. These workshops provided an opportunity for RPPA laboratories, vendors, and users to share and discuss results, the latest technology platforms, best practices, and future challenges and opportunities. The outcomes of the workshops included a number of key opportunities to advance the RPPA field and provide added benefit to existing and future participants in the RPPA research community. The purpose of this report is to share and disseminate, as a community, current knowledge and future directions of the RPPA technology.
引用
收藏
页码:1625 / 1643
页数:19
相关论文
共 115 条
[31]   Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs [J].
Henjes, F. ;
Bender, C. ;
von der Heyde, S. ;
Braun, L. ;
Mannsperger, H. A. ;
Schmidt, C. ;
Wiemann, S. ;
Hasmann, M. ;
Aulmann, S. ;
Beissbarth, T. ;
Korf, U. .
ONCOGENESIS, 2012, 1 :e16-e16
[32]   Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics [J].
Hennessy, Bryan T. ;
Gonzalez-Angulo, Ana-Maria ;
Stemke-Hale, Katherine ;
Gilcrease, Michael Z. ;
Krishnamurthy, Savitri ;
Lee, Ju-Seog ;
Fridlyand, Jane ;
Sahin, Aysegul ;
Agarwal, Roshan ;
Joy, Corwin ;
Liu, Wenbin ;
Stivers, David ;
Baggerly, Keith ;
Carey, Mark ;
Lluch, Ana ;
Monteagudo, Carlos ;
He, Xiaping ;
Weigman, Victor ;
Fan, Cheng ;
Palazzo, Juan ;
Hortobagyi, Gabriel N. ;
Nolden, Laura K. ;
Wang, Nicholas J. ;
Valero, Vicente ;
Gray, Joe W. ;
Perou, Charles M. ;
Mills, Gordon B. .
CANCER RESEARCH, 2009, 69 (10) :4116-4124
[33]   Non-parametric quantification of protein lysate arrays [J].
Hu, Jianhua ;
He, Xuming ;
Baggerly, Keith A. ;
Coombes, Kevin R. ;
Hennessy, Bryan T. J. ;
Mills, Gordon B. .
BIOINFORMATICS, 2007, 23 (15) :1986-1994
[34]   Protein Pathway Activation Mapping of Brain Metastasis from Lung and Breast Cancers Reveals Organ Type Specific Drug Target Activation [J].
Improta, Giuseppina ;
Zupa, Angela ;
Fillmore, Helen ;
Deng, Jianghong ;
Aieta, Michele ;
Musto, Pellegrino ;
Liotta, Lance A. ;
Broaddus, William ;
Petricoin, Emanuel F., III ;
Wulfkuhle, Julia D. .
JOURNAL OF PROTEOME RESEARCH, 2011, 10 (07) :3089-3097
[35]   Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment [J].
Iyengar, P ;
Espina, V ;
Williams, TW ;
Lin, Y ;
Berry, D ;
Jelicks, LA ;
Lee, H ;
Temple, K ;
Graves, R ;
Pollard, J ;
Chopra, N ;
Russell, RG ;
Sasisekharan, R ;
Trock, BJ ;
Lippman, M ;
Calvert, VS ;
Petricoin, EF ;
Liotta, L ;
Dadachova, E ;
Pestell, RG ;
Lisanti, MP ;
Bonaldo, P ;
Scherer, PE .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (05) :1163-1176
[36]   Screening for C3 Deficiency in Newborns Using Microarrays [J].
Janzi, Magdalena ;
Sjoberg, Ronald ;
Wan, Jinghong ;
Fischler, Bjorn ;
von Dobeln, Ulrika ;
Isaac, Lourdes ;
Nilsson, Peter ;
Hammarstrom, Lennart .
PLOS ONE, 2009, 4 (04)
[37]   Adjusting batch effects in microarray expression data using empirical Bayes methods [J].
Johnson, W. Evan ;
Li, Cheng ;
Rabinovic, Ariel .
BIOSTATISTICS, 2007, 8 (01) :118-127
[38]  
Kim Ki-Bum, 2008, V424, P413, DOI 10.1007/978-1-60327-064-9_32
[39]   Curcumin Treatment Suppresses IKKβ Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot Study [J].
Kim, Suejung G. ;
Veena, Mysore S. ;
Basak, Saroj K. ;
Han, Eugene ;
Tajima, Tracey ;
Gjertson, David W. ;
Starr, Joshua ;
Eidelman, Ofer ;
Pollard, Harvey B. ;
Srivastava, Meera ;
Srivatsan, Eri S. ;
Wang, Marilene B. .
CLINICAL CANCER RESEARCH, 2011, 17 (18) :5953-5961
[40]   Comprehensive molecular portraits of human breast tumours [J].
Koboldt, Daniel C. ;
Fulton, Robert S. ;
McLellan, Michael D. ;
Schmidt, Heather ;
Kalicki-Veizer, Joelle ;
McMichael, Joshua F. ;
Fulton, Lucinda L. ;
Dooling, David J. ;
Ding, Li ;
Mardis, Elaine R. ;
Wilson, Richard K. ;
Ally, Adrian ;
Balasundaram, Miruna ;
Butterfield, Yaron S. N. ;
Carlsen, Rebecca ;
Carter, Candace ;
Chu, Andy ;
Chuah, Eric ;
Chun, Hye-Jung E. ;
Coope, Robin J. N. ;
Dhalla, Noreen ;
Guin, Ranabir ;
Hirst, Carrie ;
Hirst, Martin ;
Holt, Robert A. ;
Lee, Darlene ;
Li, Haiyan I. ;
Mayo, Michael ;
Moore, Richard A. ;
Mungall, Andrew J. ;
Pleasance, Erin ;
Robertson, A. Gordon ;
Schein, Jacqueline E. ;
Shafiei, Arash ;
Sipahimalani, Payal ;
Slobodan, Jared R. ;
Stoll, Dominik ;
Tam, Angela ;
Thiessen, Nina ;
Varhol, Richard J. ;
Wye, Natasja ;
Zeng, Thomas ;
Zhao, Yongjun ;
Birol, Inanc ;
Jones, Steven J. M. ;
Marra, Marco A. ;
Cherniack, Andrew D. ;
Saksena, Gordon ;
Onofrio, Robert C. ;
Pho, Nam H. .
NATURE, 2012, 490 (7418) :61-70